MeSH D012770 - cardiogenic shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Sanofi | Inamrinone | Inocor | 1984-07-31 | |||
| Eli Lilly | Glucagon | Baqsimi | 2019-12-16 | $652.8 M | Q2/23-Q3/24 | |
| Glucagon | Glucagon | 1982-01-01 | ||||
| Hospira | Inamrinone | Amrinone | 1998-08-03 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
80%4/5
Phase 3
47%7/15
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use